What is the recommended treatment regimen for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Regimen for Syphilis

The recommended treatment for syphilis is benzathine penicillin G 2.4 million units IM in a single dose for adults with primary or secondary syphilis. 1

Treatment Regimens by Stage and Population

Primary and Secondary Syphilis

  • Adults: Benzathine penicillin G 2.4 million units IM in a single dose 1
  • Children: Benzathine penicillin G 50,000 units/kg IM, up to the adult dose of 2.4 million units in a single dose 1

Penicillin Allergy (Non-pregnant adults)

  • Doxycycline 100 mg orally twice daily for 2 weeks 1, 2
  • Alternative: Tetracycline 500 mg orally 4 times daily for 2 weeks 1

Late Latent Syphilis

  • Benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (7.2 million units total) 3

Neurosyphilis

  • Aqueous crystalline penicillin G 18-24 million units per day, administered as 3-4 million units IV every 4 hours for 10-14 days 1

Congenital Syphilis

  • Proven or highly probable disease: Aqueous crystalline penicillin G 100,000–150,000 units/kg/day, administered as 50,000 units/kg/dose IV every 12 hours during the first 7 days of life and every 8 hours thereafter for a total of 10 days 1
  • Alternative: Procaine penicillin G 50,000 units/kg/dose IM in a single daily dose for 10 days 1

Important Clinical Considerations

Follow-Up

  • Patients should be re-examined clinically and serologically at 3 months and 6 months after treatment 1
  • Treatment failure is indicated by:
    • Persistence or recurrence of signs/symptoms
    • Sustained fourfold increase in nontreponemal test titer
    • Failure of nontreponemal test titers to decline fourfold within 3-6 months after therapy 1

HIV Testing

  • All patients with syphilis should be tested for HIV infection 1
  • In high HIV prevalence areas, patients with primary syphilis should be retested for HIV after 3 months if initial test was negative 1

Special Situations

Neurologic Involvement

  • Patients with neurologic symptoms (meningitis, cranial nerve abnormalities) or ophthalmic disease should undergo CSF analysis and appropriate evaluation 1
  • Treatment should be guided by CSF results

Treatment Failure

  • Re-evaluate for HIV infection
  • Perform lumbar puncture unless reinfection is certain
  • Re-treat with three weekly injections of benzathine penicillin G 2.4 million units IM 1

Common Pitfalls and Caveats

  1. Jarisch-Herxheimer reaction: Patients should be warned about this potential reaction that can occur within 24 hours of treatment

  2. Penicillin alternatives: While doxycycline is an acceptable alternative for non-pregnant penicillin-allergic patients, it has less clinical experience supporting its use 1

  3. Recent shortages: Benzathine penicillin G shortages have been reported, potentially requiring alternative treatments in some settings 4

  4. Serologic follow-up: Nontreponemal test titers may decline more slowly in patients with previous syphilis infections, complicating assessment of treatment response 1

  5. Partner management: Sexual partners need to be identified, tested, and treated based on exposure timeframes (3 months plus duration of symptoms for primary syphilis, 6 months plus duration of symptoms for secondary syphilis) 1

Despite some studies showing comparable efficacy of azithromycin to benzathine penicillin G 5, 6, the CDC guidelines consistently recommend penicillin as first-line therapy due to its long history of effectiveness and the potential for resistance with other antibiotics.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.